✦ LIBER ✦

Phase I trial of sorafenib in patients with recurrent or progressive malignant glioma

✍ Scribed by Nabors, L. B.; Supko, J. G.; Rosenfeld, M.; Chamberlain, M.; Phuphanich, S.; Batchelor, T.; Desideri, S.; Ye, X.; Wright, J.; Gujar, S.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of thalidomide and proc

✍ Jimmy Ruiz; Doug Case; Gina Enevold; Robin Rosdhal; Stephen B. Tatter; Thomas L. 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 205 KB

Phase II Trial of Cisplatin Plus Temozol

✍ Antonio Silvani; Marica Eoli; Andrea Salmaggi; Elena Lamperti; Elio Maccagnano; 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 59 KB

Phase II Trial of Cisplatin Plus Temozol

✍ Antonio Silvani; Marica Eoli; Andrea Salmaggi; Elena Lamperti; Elio Maccagnano; 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 59 KB

Ridaforolimus for patients with progress

✍ David A. Reardon; Patrick Y. Wen; W. K. Alfred Yung; Lori Berk; Narayana Narasim 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 691 KB

Phase II trial of ritonavir/lopinavir in

✍ Manmeet S. Ahluwalia; Carol Patton; Glen Stevens; Tanya Tekautz; Lilyana Angelov 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 192 KB

Phase I Dose Escalation Trial of Vandeta

✍ Emma C. Fields; Denise Damek; Laurie E. Gaspar; Arthur K. Liu; Brian D. Kavanagh 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 387 KB